The global tebuconazole market size is projected to reach US$ 1,466.14 million by 2034 from US$ 949.29 million in 2025. The market is anticipated to register a CAGR of 4.95% during the forecast period 2026–2034. Tebuconazole—a systemic triazole fungicide that acts as a demethylation inhibitor (DMI) by disrupting fungal cell wall synthesis—delivers broad-spectrum curative,...